Johnson & Johnson JNJ MEDTECH — Selling, marketing and administrative expenses

Other segment segments

Similar metrics at other companies

KNMedTech & Specialty Audio — Adjusted Selling and Administrative Expenses

$3.7M+8.8%

ANGOMed Tech — Cost of sales (exclusive of intangible amortization)

$13.99M+19.0%

BSXMedSurg — Selling, general and administrative expenses

$557M+8.8%

BAXMedical Products & Therapies — Selling, general and administrative expenses

$290M+1.4%

SYKMedSurg and Neurotechnology: — Selling, general and administrative expenses

$930M+8.3%

BDXMedical Essentials — Selling and administrative expense

$185M+12.8%

Questions, answered.

What is Johnson & Johnson's MEDTECH — selling, marketing and administrative expenses?

Johnson & Johnson (JNJ) reported MEDTECH — selling, marketing and administrative expenses of $2.91B in Q1 2026.

How has Johnson & Johnson's MEDTECH — selling, marketing and administrative expenses changed year-over-year?

Johnson & Johnson's MEDTECH — selling, marketing and administrative expenses increased by 9.4% year-over-year, from $2.66B to $2.91B.

What is the long-term trend for Johnson & Johnson's MEDTECH — selling, marketing and administrative expenses?

Over 3 years (2022 to 2025), Johnson & Johnson's MEDTECH — selling, marketing and administrative expenses has grown at a 6.0% compound annual growth rate (CAGR), from $9.54B to $11.35B.

What does MEDTECH — selling, marketing and administrative expenses mean?

Represents the operating expenses incurred to support the sales, marketing, and general administration of the MedTech segment. This includes costs for sales forces, advertising, and corporate overhead allocated to the segment.